Jim Simons
BNR

Jim Simons’s Burning Rock Biotech BNR Stock Holding History

Jim Simons’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
52,838
+17,431
+49% +$247K ﹤0.01% 2641
2026
Q1 		$571K Buy
35,407
+4,290
+14% +$112K ﹤0.01% 2549
2025
Q4 		$627K Sell
31,117
-600
-2% -$8.76K ﹤0.01% 2485
2025
Q3 		$274K Hold
31,717
– – ﹤0.01% 3037
2025
Q2 		$100K Hold
31,717
– – ﹤0.01% 3298
2025
Q1 		$143K Sell
31,717
-600
-2% -$3.75K ﹤0.01% 3138
2024
Q4 		$218K Sell
32,317
-600
-2% -$2.76K ﹤0.01% 3141
2024
Q3 		$107K Sell
32,917
-700
-2% -$3.86K ﹤0.01% 3246
2024
Q2 		$217K Sell
33,617
-653
-2% -$4.97K ﹤0.01% 3020
2024
Q1 		$250K Sell
34,270
-260
-0.8% -$2.17K ﹤0.01% 3154
2023
Q4 		$321K Sell
34,530
-670
-2% -$6.16K ﹤0.01% 2958
2023
Q3 		$341K Sell
35,200
-410
-1% -$6.4K ﹤0.01% 2873
2023
Q2 		$766K Sell
35,610
-680
-2% -$18K ﹤0.01% 2633
2023
Q1 		$1.02M Sell
36,290
-1,660
-4% -$49.7K ﹤0.01% 2470
2022
Q4 		$854K Sell
37,950
-16,130
-30% -$368K ﹤0.01% 2624
2022
Q3 		$1.29M Sell
54,080
-55,740
-51% -$1.8M ﹤0.01% 2339
2022
Q2 		$3.2M Buy
109,820
+98,460
+867% +$4.4M ﹤0.01% 1868
2022
Q1 		$1.05M Sell
11,360
-5,179
-31% -$450K ﹤0.01% 2690
2021
Q4 		$1.58M Buy
16,539
+15,529
+1,538% +$2.13M ﹤0.01% 2340
2021
Q3 		$181K Buy
+1,010
New +$225K ﹤0.01% 3226

Other funds holding BNR

CL
CRCM LP San Francisco, California $144M AUM 26.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jim Simons's BNR Position: Q2 2026 in Review

Jim Simons increased its Burning Rock Biotech (BNR) stake by 49% in Q2 2026, buying an estimated $247K and bringing the position to 52,838 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Jim Simons first reported a position in BNR in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.2M in Q2 2022. 12 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Jim Simons held 52,838 shares of Burning Rock Biotech worth $442K as of Q2 2026.
  • Jim Simons bought 17,431 Burning Rock Biotech shares in Q2 2026, an estimated $247K.
  • Burning Rock Biotech made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2641 holding.
  • Jim Simons first reported a position in Burning Rock Biotech in Q3 2021 and has held it in 20 quarters since.
  • Jim Simons's Burning Rock Biotech position peaked at $3.2M in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.